Edgewise Therapeutics Inc. Common Stock vs Vicor Corporation Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while Vicor Corporation Common Stock trades at $237.5 (market cap $12.30B). The key difference: Vicor Corporation Common Stock is far larger — about 3.1× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Vicor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Vicor Corporation Common Stock for 0 Days on average.
| EWTX | VICR | |
|---|---|---|
Market Cap | $3.94B | $12.30B |
Volume | 810,104 | 1,052,269 |
Sector | Health | Technology |
52-Week High | $48.35 | $379.78 |
52-Week Low | $14.89 | $57.31 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $11.86B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Vicor Corporation designs, manufactures, and markets modular power components and complete power systems, serving high-performance computing, data center, industrial, automotive, and aerospace and defense markets.
Read more on VICR →